Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Swiss Medical Weekly
|
February 5, 2010
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland
K Overbeck, J F Dufour, B Müllhaupt, et al.
The American Journal of Physiology
|
September 1, 1996
Role of cholecystokinin as a regulator of solid and liquid gastric emptying in humans
J Borovicka, C Kreiss, K Asal, et al.
Journal of Viral Hepatitis
|
October 21, 2006
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
Beat Helbling, Wolfram Jochum, Ivan Stamenic, et al.
Gut
|
July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection
B Helbling, K Overbeck, J-J Gonvers, et al.
Journal of Viral Hepatitis
|
June 24, 2006
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis
B Meyer-Wyss, P Rich, Hp Egger, et al.
Neurogastroenterology and Motility
|
December 23, 2014
Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment
J Tack, F Zerbib, K Blondeau, et al.
Nature
|
March 28, 2009
The impact and recovery of asteroid 2008 TC(3)
P Jenniskens, M H Shaddad, D Numan, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Swiss Medical Weekly
|
February 5, 2010
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland
K Overbeck, J F Dufour, B Müllhaupt, et al.
The American Journal of Physiology
|
September 1, 1996
Role of cholecystokinin as a regulator of solid and liquid gastric emptying in humans
J Borovicka, C Kreiss, K Asal, et al.
Journal of Viral Hepatitis
|
October 21, 2006
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
Beat Helbling, Wolfram Jochum, Ivan Stamenic, et al.
Gut
|
July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection
B Helbling, K Overbeck, J-J Gonvers, et al.
Journal of Viral Hepatitis
|
June 24, 2006
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis
B Meyer-Wyss, P Rich, Hp Egger, et al.
Neurogastroenterology and Motility
|
December 23, 2014
Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment
J Tack, F Zerbib, K Blondeau, et al.
Nature
|
March 28, 2009
The impact and recovery of asteroid 2008 TC(3)
P Jenniskens, M H Shaddad, D Numan, et al.
Page
of 4